Healthcare of Ontario Pension Plan Trust Fund Has $58.28 Million Stock Position in VanEck Pharmaceutical ETF $PPH

Posted by Andrew Walz on Jul 26th, 2026

Healthcare of Ontario Pension Plan Trust Fund lowered its position in VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report) by 45.5% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 561,000 shares of the company’s stock after selling 469,000 shares during the quarter. Healthcare of Ontario Pension Plan Trust Fund owned approximately 5.91% of VanEck Pharmaceutical ETF worth $58,277,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. AlphaCore Capital LLC purchased a new stake in shares of VanEck Pharmaceutical ETF during the 4th quarter worth about $31,000. Group One Trading LLC acquired a new stake in shares of VanEck Pharmaceutical ETF during the 4th quarter valued at about $36,000. IFP Advisors Inc grew its stake in shares of VanEck Pharmaceutical ETF by 53.7% in the 3rd quarter. IFP Advisors Inc now owns 438 shares of the company’s stock valued at $40,000 after buying an additional 153 shares in the last quarter. Advisory Services Network LLC bought a new stake in shares of VanEck Pharmaceutical ETF in the 3rd quarter valued at approximately $41,000. Finally, EFG International AG bought a new stake in shares of VanEck Pharmaceutical ETF in the 4th quarter valued at approximately $44,000.

VanEck Pharmaceutical ETF Stock Performance

NASDAQ:PPH opened at $110.63 on Friday. The stock’s 50 day moving average price is $106.53 and its 200 day moving average price is $105.64. VanEck Pharmaceutical ETF has a 52 week low of $81.74 and a 52 week high of $112.58. The company has a market capitalization of $961.37 million, a P/E ratio of 20.21 and a beta of 0.46.

VanEck Pharmaceutical ETF Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, July 7th. Shareholders of record on Wednesday, July 1st were given a $0.6248 dividend. This represents a $2.50 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend was Wednesday, July 1st.

VanEck Pharmaceutical ETF Profile

(Free Report)

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.